Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Asthma Health Center

Font Size

FDA Warns About Asthma Drug, Xolair

Extreme Allergic Reactions Seen in Some Patients Using Injected Drug
By Carol Cropper
WebMD Health News
Reviewed by Louise Chang, MD

Feb. 21, 2007 -- The FDA is calling for a "black box" label warning for the asthma drug Xolair, alerting users it can cause potentially life-threatening allergic reactions.

The FDA issued the alert after reviewing 48 cases of anaphylaxis -- life-threatening allergic reactions -- submitted to the agency from June 2003, when Xolair was approved, through December 2005.

These cases included symptoms of bronchospasm (narrowing of airways), difficulty breathing, drop in blood pressure, fainting, hives, and swelling of the throat or tongue.

Nearly 15% of the patients required hospitalization. No deaths were reported.

The drug, which is injected, is also known by the generic name omalizumab.

It is approved for use in asthma patients aged 12 and older who have moderate to severe persistent asthma, and who have tested positive for a perennial aerial allergen -- such as pollen, grass, or dust.

The drug is a secondary treatment, recommended for those whose symptoms have not been adequately controlled with inhaled steroids.

Delayed Reaction Possible

The FDA alert warns that patients can have a delayed reaction from two to 24 hours -- or longer -- after injection.

It adds that patients who have not reacted in the past can still develop anaphylaxis following a later dose.

In about 39,500 patients who took Xolair, the FDA says anaphylaxis occurred in at least 0.1% of those treated.

The drug is currently injected in a medical setting once every two or four weeks, depending on the patient, according to an email response from the FDA.

Now, the FDA is asking health care professionals who administer Xolair to observe patients for at least two hours after giving the injection and to be prepared to manage life-threatening anaphylaxis if it occurs.

Also, patients who take Xolair should be told of the possibility of a delayed reaction and be able to recognize the signs and symptoms of anaphylaxis, the FDA says in its alert.

Patients using Xolair should carry medical contact information and an epinephrine auto-injector (EpiPen). They should also be prepared to begin treatment on themselves while they seek immediate medical attention should anaphylaxis occur.

When Is Your Asthma Worse?

When Is Your Asthma Worse?

Take the WebMD Asthma assessment to get Personalized Action Plan

Start Now

Today on WebMD

Lung and bronchial tube graphic
5 common triggers.
group jogging in park
Should you avoid fitness activities?
asthma inhaler
Learn about your options.
man feeling faint
What’s the difference?
Madison Wisconsin Capitol
woman wearing cpap mask
red wine pouring into glass
Woman holding inhaler
Man outdoors coughing
Lung and bronchial tube graphic
10 Worst Asthma Cities